2016 annual financial data

Vistagen Therapeutics, Inc. 2016 Operating margin

Vistagen Therapeutics, Inc. 2016 operating margin with verified reported values.

Direct answer

Operating margin was Not calculable.

Operating income was -17,850,200 USD and net income was -47,220,500 USD.
Operating cash flow was -4,808,500 USD.

Get free Vistagen Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-17,850,200 USD
Net income
-47,220,500 USD
Operating cash flow
-4,808,500 USD